CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis-Reference-Cited by-同舟云学术

CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis

Published:2007 Issue:5 Volume:56 Page:1685-1693
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Prasse Antje,Pechkovsky Dmitri V.,Toews Galen B.,Schäfer Markus,Eggeling Stephan,Ludwig Corinna,Germann Martin,Kollert Florian,Zissel Gernot,Müller-Quernheim Joachim

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference33 articles.

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias

2. Advances in the treatment of rheumatic interstitial lung disease

3. A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18

4. Gene Expression in Bronchoalveolar Lavage Cells from Scleroderma Patients

5. Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: A sensitive indicator of active pulmonary fibrosis

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease;Rheumatic Disease Clinics of North America;2024-08

2. Pro-Fibrotic Effects of CCL18 on Human Lung Fibroblasts Are Mediated via CCR6;Cells;2024-01-26

3. Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases;Pharmacology & Therapeutics;2024-01

4. Homeostatic chemokines as putative therapeutic targets in idiopathic pulmonary fibrosis;Trends in Immunology;2023-12

5. Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF): Protocol for a Multicenter Prospective Study;JMIR Research Protocols;2023-11-17